24/7 Customer Support

Talk to Clare

+1 339 368 6001

Publication dates

Cell Therapy Industry, October 2014 Market Reports from Top Publishers

You might be interested in: Cancer, Medical Equipment, Therapeutics, more »


 
1-10 of about 200 reports for Cell Therapy

Analysis of the Global Stem Cell Market

Analysis of the Global Stem Cell Market

  • $ 6 000
  • Industry report
  • October 2014
  • by Frost & Sullivan

The key to Transforming Future of Diagnostic and Therapeutic Medicine This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the ...

Bioheart, Incorporation

Bioheart, Incorporation

  • $ 55
  • Company report
  • October 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Bioheart, Incorporation compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio ...

Shanghai Jiaoda Onlly Co., Ltd.

Shanghai Jiaoda Onlly Co., Ltd.

  • $ 55
  • Company report
  • October 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Shanghai Jiaoda Onlly Co., Ltd. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ...

Peptidream Inc

Peptidream Inc

  • $ 55
  • Company report
  • October 2014
  • by Wright Investors' Service

A textual analysis of the financial results for Peptidream Inc compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

Biolife Solutions, Inc. (Symbol:BLFS) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

BrainStorm Cell Therapeutics Inc. (Symbol:BCLI) SWOT Analysis, Strategy, Revenues and Profits

BrainStorm Cell Therapeutics Inc. (Symbol:BCLI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Develops autologous stem cell therapies for debilitating neurodegenerative diseases, such as amyotrophic lateral sclerosis, multiple sclerosis and parkinson's disease. It develops nurown technology ...

International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

International Stem Cell Corporation (Symbol:ISCO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

MolMed S.p.A. (Symbol:MLM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Is a cell therapy product for the treatment of haematological malignancies. The company's ngr-htnf is a recombinant biological drug for the treatment of solid tumours. It applies its technologies ...

Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

Optimer Pharmaceuticals, Inc. (Symbol:OPTR) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Vitro Diagnostics, Inc. (Symbol:VODG) SWOT Analysis, Strategy, Revenues and Profits

Vitro Diagnostics, Inc. (Symbol:VODG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • October 2014
  • by Global Data

... Vitro biopharma announces advances in stem cell therapy without transplantsmar 11, 2014: vitro biopharma products advance pancreatic cancer researchfeb 11, 2014: vitro biopharma revenues increase ...

About 700 reports for Cell Therapy

Download Unlimited Documents from Trusted Public Sources

Pct Annual Report 2013

  • Annual Report to Shareholders
  • January 2013
    156 pages
  • Equity Market  

    Common Stock  

    Cell Therapy  

  • United States  

View report >

Annual Report 2014

January 2014

1 Companies for Cell Therapy

Read our Company Profiles

Bioheart Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.